• Ngwaahịa
ibe

Ngwaahịa

Heparin sodium nke Deebio maka ọgwụgwọ mgbochi ọrịa thromboembolism


  • Ọ BỤGHỊ:9041-08-1
  • Koodu HS:3001.9010.00
  • Ọrụ faịlụ:Chinese-GMP, DMF
  • Ọkọlọtọ Pharmacopoeia:EP/USP
  • Nkọwa ngwaahịa

    Mkpado ngwaahịa

    Nkọwa

    1. Characters: White ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ, nke ukwuu hygroscopic.

    2. Isi Iyi: Porcine eriri afọ mucosa.

    3. Usoro: Heparin sodium na-amịpụtara si ike porcine eriri afọ mucosa.

    4. Ngosipụta na ojiji: A na-ejikarị ngwaahịa a maka igbochi ọrịa thromboembolic, karịsịa maka mkpa nke anticoagulant ngwa ngwa, dị ka: 1. Nnukwu ma ọ bụ na-adịghị ala ala venous thrombosis ma ọ bụ enweghị ịrịba ọbara eruba dynamic mgbanwe nke pulmonary embolism (PE) .Heparin. nwere ike ịkwụsị ndọtị embolus iji wepụta oge maka thrombolysis nke anụ ahụ na-akpaghị aka.2. Mgbochi na ọgwụgwọ nke Atrial fibrillation na embolism.3. Ọgwụgwọ n'oge mgbasa intravascular coagulation (DIC).4. Mgbochi na ọgwụgwọ thrombosis mpụta ma ọ bụ myocardial infarction.5. Ndị ọzọ in vitro anticoagulation: dị ka ịwa ahụ obi, mgbasa ọbara in vitro, hemodialysis, angiography, nwekwara ike iji maka mmịnye ma ọ bụ nkwadebe ụdị ọbara, ugbu a isi ihe na-egosi ngwa ngwa heparin bụ thrombosis miri emi (DVT), PE na thrombosis. na nnukwu ihe ize ndụ ndị ọrịa.

    img (2)
    img (3)

    Gịnị mere anyị?

    · Gafere GMP nke China

    · afọ 27 nke akụkọ ihe mere eme nke enzyme R&D

    · A na-achọpụta ihe ọkụkụ

    · Soro USP,EPna ọkọlọtọ ọkọlọtọ

    · Mbupụ gaa na mba na mpaghara iri atọ

    · Nwere ikike nke njikwa sistemụ dị mma dịka US FDA, Japan PMDA, South Korea MFDS, wdg.

    Nkọwapụta

    Nnwale ihe

    Nkọwapụta ụlọ ọrụ

    EP

    USP

    Ndị agwa

    White ma ọ bụ fọrọ nke nta ka ọ bụrụ ntụ ntụ, ukwuu hygroscopic

    njirimara

    Thrombotest: kwekọrịtara

    njirimara Chromatographic: kwekọrọ

    1H NMR Spectrum: Dabara

    1H NMR Spectrum: Dabara

    Chromatography Liquid: Dabara

    Arọ-nkezi arọ molekụla: 15000 ~ 19000

    Sodium: dabara

    Sodium: dabara

    Anti-factor Xa ka ihe mgbochi IIa ruru: 0.9 ~ 1.1

    Anti-factor Xa ka ihe mgbochi IIa ruru: 0.9 ~ 1.1

    Nnwale

    Ido anya na agba

    Idozi: doro anya, Agba: site na 5 ma ọ bụ karịa

    ————

    Nitrogen

    1.52.5%(akọrọ ihe)

    1.32.5%(akọrọ ihe)

    Nucleotidic adịghị ọcha

    A2600.15 (4 mg / ml)

    ≤ 0.1(w/w)

    Ihe ndị metụtara ya

    Dabara

    ————

    Oke nke galactosamine na mkpokọta hexosamine

    ————

    ≤ 1.0%

    Chondroitin sulfate karịrị akarị

    ————

    Dabara

    pH

    5.58.0(1%)

    5.57.5(1%)

    Ọnwụ na ihicha

    ≤ 8.0%(60℃ kpọrọ nkụ na Vacuum, 3h)

    ≤5.0%(60℃ kpọrọ nkụ na Vacuum, 3h)

    Ihe fọdụrụ na mgbanye

    ————

    28.0%41.0%

    Ọgwụ nje endotoxin

    ≤ 0.01 IU / Ngalaba Mba Nile nke Heparin

    ≤ 0.03 USP U/Ngalaba Mba Nile nke Heparin

    Igwe dị arọ

    ≤30pm

    ≤30pm

    Sodium

    10.513.5%(akọrọ ihe)

    ————

    Protein

    ≤0.5%(akọrọ ihe)

    ≤0.1%(Oke ibu)

    Ihe omume

    ≥ 180 IU/mg(akọrọ ihe)

    ≥ 180 USP U/mg(akọrọ ihe)

    Microbial adịghị ọcha

    TAMC

    ≤1000cfu/g

    ≤1000cfu/g

    TYMC

    ≤100cfu/g

    ≤100cfu/g

    E.coli

    Dabara

    Dabara

    Staphylococcus aureus

    Dabara

    Dabara

    Salmonella

    Dabara

    Dabara


  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya
    AEO
    EHS
    EU-GMP
    GMP
    HACCP
    ISO
    Bipụta
    PMDA
    onye mmekọ_bu
    onye mmekọ_ọzọ
    Ngwaahịa na-ekpo ọkụ - map saịtị - AMP Mobile